Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Biomimetic electrospun scaffolds for engineered heart tissue: from design parameters to drug testing platforms

Vaiciuleviciute R., Alaburda A., Uzieliene I., Kistamás K., Lengyel M., Dinnyés A.

Narrative Review on Cardiovascular Disease, published in Front Bioeng Biotechnol (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Front Bioeng Biotechnol (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41743838
PMCID
PMC12929422
DOI
10.3389/fbioe.2026.1711698
Citations
2

Abstract (original English)

Electrospun nanofibers have emerged as a promising platform for cardiac tissue engineering, offering unique opportunities to recapitulate the native myocardial extracellular matrix (ECM) architecture. This comprehensive review examines the critical design parameters affecting cardiomyocyte function and maturation on electrospun scaffolds, including fiber diameter, material composition, alignment, and pore architecture. Recent advances in conductive polymers and hybrid material systems have shown particular promise for enhancing electrical coupling and functional maturation of stem cell-derived cardiomyocytes. However, significant challenges remain in achieving complete cardiomyocyte maturation, particularly regarding calcium handling properties and metabolic characteristics. This review synthesizes current knowledge on technical characteristics of biomimetic nanofibrous scaffolds, identifying future directions for translating these approaches toward realistic cardiac models and potential clinical cardiac regenerative applications.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research